WallStSmart
YCBD

cbdMD Inc

NYSE MKT: YCBD · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$0.85
-2.02% today

Updated 2026-04-30

Market cap
$10.18M
P/E ratio
1.62
P/S ratio
0.53x
EPS (TTM)
$0.60
Dividend yield
52W range
$0 – $3
Volume
1.8M

cbdMD Inc (YCBD) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20152016201720182019202020212022202320242025
Revenue$12540.00$2.03M$4.47M$459091.00$23.65M$41.88M$44.48M$35.40M$24.16M$19.48M$19.19M
Revenue growth (YoY)+16100.7%+120.3%-89.7%+5051.8%+77.1%+6.2%-20.4%-31.8%-19.3%-1.5%
Cost of revenue$7620.00$1.62M$1.36M$326556.00$9.14M$15.51M$15.51M$14.90M$11.12M$8.64M$8.35M
Gross profit$4920.00$413130.00$3.12M$132535.00$14.51M$26.37M$28.97M$20.50M$13.04M$10.85M$10.84M
Gross margin39.2%20.3%69.7%28.9%61.4%63.0%65.1%57.9%54.0%55.7%56.5%
R&D$424450.00$1.42M$633392.00$173038.00$39021.00$33856.00
SG&A$1.79M$28.88M$23.06M$21.77M$15.81M$11.19M$8.44M$7.00M
Operating income$-1.30M$-3.73M$-239291.00$-1.80M$-14.36M$-17.58M$-19.62M$-17.31M$-9.27M$-3.19M$-2.16M
Operating margin-10360.4%-183.8%-5.3%-391.4%-60.7%-42.0%-44.1%-48.9%-38.4%-16.4%-11.3%
EBITDA$-3.69M$-168015.00$-1.57M$-14.07M$-15.68M$-17.36M$-14.34M$-6.34M$-1.37M$-366668.00
EBITDA margin0.0%-181.6%-3.8%-343.0%-59.5%-37.4%-39.0%-40.5%-26.3%-7.0%-1.9%
EBIT$-3.73M$-239291.00$-1.80M$-14.36M$-17.58M$-19.62M$-17.31M$-9.27M$-3.19M$-2.16M
Interest expense$0.00$154977.00$500627.00$955.00$71.93M$57.69M$28930.00$16246.00$29507.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-1.13M$-3.36M$-1.74M$-412075.00$-50.43M$12.60M$-23.39M$-70.08M$-22.94M$-3.70M$-2.04M
Net income growth (YoY)-196.8%+48.2%+76.3%-12137.6%+125.0%-285.6%-199.6%+67.3%+83.9%+44.8%
Profit margin-9017.9%-165.2%-38.9%-89.8%-213.2%30.1%-52.6%-198.0%-95.0%-19.0%-10.6%